000 04225nam a22003975i 4500
001 294368
003 MX-SnUAN
005 20160429155143.0
007 cr nn 008mamaa
008 150903s2006 gw | o |||| 0|eng d
020 _a9783540308225
_99783540308225
024 7 _a10.1007/3540308229
_2doi
035 _avtls000347556
039 9 _a201509030444
_bVLOAD
_c201404121433
_dVLOAD
_c201404091211
_dVLOAD
_y201402070934
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC681-688.2
100 1 _aSchultheiss, H. -P.
_eeditor.
_9327876
245 1 0 _aChronic Viral and Inflammatory Cardiomyopathy /
_cedited by H. -P. Schultheiss, J. -F. Kapp, G. Grötzbach.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2006.
300 _axviii, 361 páginas 68 ilustraciones
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aErnst Schering Research Foundation Workshop,
_x0947-6075 ;
_v55
500 _aSpringer eBooks
505 0 _aChronic Viral and Inflammatory Cardiomyopathy -- Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis -- Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy -- Viruses -- Frontiers in Viral Diagnostics -- Invited for Debate: Is Virus Persistence a Determinant for Disease Progression? -- Parvovirus B19: The Causative Agent of Dilated Cardiomyopathy or a Harmless Passenger of the Human Myocard? -- Parvovirus B19: A New Emerging Pathogenic Agent of Inflammatory Cardiomyopathy -- Role of Hepatitis C Virus in Cardiomyopathies -- Immunity and Autoimmunity -- Recent Insights into the Role of Host Innate and Acquired Immunity Responses -- The Significance of Autoimmunity in Myocarditis -- The Roles of Immunity and Autoimmunity in Chronic Heart Failure -- Clinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy -- Cardiac Remodeling -- Inflammation and Cardiac Remodeling During Viral Myocarditis -- Inflammatory Cardiomyopathy: There Is a Specific Matrix Destruction in the Course of the Disease -- Invited for Debate: Is There a Virus-Specific Matrix Destruction in the Course of Disease in Dilated Cardiomyopathy? -- Diagnosis and Treatment -- New Non-invasive Approaches for the Diagnosis of Cardiomyopathy: Magnetic Resonance Imaging -- New Therapeutics Targets in Chronic Viral Cardiomyopathy -- Myocarditis and Inflammatory Cardiomyopathy: Histomorphological Diagnosis -- Anti-viral Treatment in Patients with Virus-Induced Cardiomyopathy -- Immunosuppressive Treatment of Chronic Non-viral Myocarditis -- Immunoadsorption in Dilated Cardiomyopathy.
520 _aThe interconnectedness of genetics and susceptibility to disease, viral and non-viral inflammation, and the role of immunity and the development of autoimmunity is a fascinating and much discussed topic in cardiomyopathy. This publication constitutes the outcome of an ESRF meeting held together with the German Research Foundation. Clinical researchers, immunologists, virologists and molecular biologists provide the latest findings in their fields, advancing our understanding of what causes chronic viral and inflammatory cardiomyopathy, why it affects a subset of individuals while sparing the majority, how we can develop better therapies, and whether the disease can be prevented. Special emphasis is placed on the role of viruses in the aetiology and pathogenesis of cardiomyopathy. The editors are convinced that the broad spectrum covered by this state-of-the-art publication will be of exceptional value to its readers.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aKapp, J. -F.
_eeditor.
_9327877
700 1 _aGrötzbach, G.
_eeditor.
_9327878
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783540239710
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/3-540-30822-9
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c294368
_d294368